Comparison of two statistical indicators in communicating epidemiological results to the population: a randomized study in a high environmental risk area of Italy

被引:0
|
作者
Baccini, Michela [1 ,4 ]
Ghirardi, Laura [1 ,2 ]
Farinella, Domenica [3 ]
Biggeri, Annibale [1 ,4 ]
机构
[1] Univ Florence, Dept Stat, Comp Sci, Applicat, Viale Morgagni 59, I-50134 Florence, Italy
[2] Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden
[3] Univ Messina, Dept Polit Sci & Law, Via T Cannizzaro 278, I-98122 Messina, Italy
[4] ISPO Canc Prevent & Res Inst, Biostat Unit, Via Cosimo II Vecchio 2, I-50139 Florence, Italy
关键词
Randomized trial; Environmental health; Health impact assessment; Risk communication; Statistical indicators; Time needed to harm; Propensity score; PERCEPTION; NUMERACY; BENEFIT; EXPERT; SCALE;
D O I
10.1186/s12889-019-7003-y
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundWhen communicating risks to the general population, the format of the epidemiological results may affect individual reactions. In environmental epidemiology, no study has compared the use of different statistical formats in communicating results to the population. The aim of this paper is to investigate whether the degree of concern expressed by residents of a high environmental risk site, regarding epidemiological results on cancer mortality in the area where they live, is influenced by the statistical indicator used in communication.MethodsA sample of residents in the high environmental risk area of Livorno (Italy) was randomized to respond to different questionnaires, in which the same epidemiological results were expressed by two alternative risk indexes: percent excess risk and time needed to harm, defined as the number of days that one has to wait for, on average, to observe 1 death in excess in respect to the baseline. Participants were asked to express their concern on a quantitative scale or to rank different diseases according to their impressions. The statistical analysis was performed using an Inverse Probability of Treatment Weighting approach based on propensity score, in order to account for sample stratification and adjust for unbalance between groups occurring despite randomization.ResultsThe probability of high concern levels was larger under time needed to harm than under percent excess, with a difference between proportions of 6.7% (95% Confidence Interval, 0.6,12.8%). Mortality from sexual glands cancer was ranked as more worrisome and mortality from thyroid gland cancer as less worrisome under time needed to harm than under percent excess. No rank change was found for lung cancer. Larger differences between the two indicators arose in subjects with higher education or better numerical skills.ConclusionsCommunicating epidemiological results to the population is not a neutral task. The degree of concern and judgments when comparing results on different diseases may depend on the risk indicators used. Translating scientific results into lay language should not exempt from careful evaluation of the impact of this translation on lay people.
引用
收藏
页数:9
相关论文
共 30 条
  • [21] Residential distance from high-voltage overhead power lines and risk of Alzheimer's dementia and Parkinson's disease: a population-based case-control study in a metropolitan area of Northern Italy
    Gervasi, Federico
    Murtas, Rossella
    Decarli, Adriano
    Russo, Antonio Giampiero
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2019, 48 (06) : 1949 - 1957
  • [22] Comparison of Two Different Therapeutic Regimens with Azacitidine and Lenalidomide (Combined versus Sequential) in Higher-Risk Myelodysplastic Syndromes. Update of Long-Term Results of a Randomized Phase II Multicenter Study
    Finelli, Carlo
    Clissa, Cristina
    Follo, Matilde Y.
    Parisi, Sarah
    Fogli, Miriam
    Mongiorgi, Sara
    Capodanno, Isabella
    Bosi, Costanza
    Castagnari, Barbara
    Candoni, Anna
    Crugnola, Monica
    Giannini, Maria Benedetta
    Gobbi, Marco
    Leonardi, Giovanna
    Rigolin, Gian Matteo
    Russo, Domenico
    Tosi, Patrizia
    Pellagatti, Andrea
    Boultwood, Jacqueline
    Cocco, Lucio
    Cavo, Michele
    [J]. BLOOD, 2018, 132
  • [23] Results of the EICESS-92 study:: Two randomized trials of Ewing's sarcoma treatment -: Cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients
    Paulussen, Michael
    Craft, Alan W.
    Lewis, Ian
    Hackshaw, Allan
    Douglas, Carolyn
    Dunst, Juergen
    Schuck, Andreas
    Winkelmann, Winfried
    Koehler, Gabriele
    Poremba, Christopher
    Zoubek, Andreas
    Ladenstein, Ruth
    van den Berg, Henk
    Hunold, Andrea
    Cassoni, Anna
    Spooner, David
    Grimer, Robert
    Whelan, Jeremy
    McTiernan, Anne
    Juergens, Herbert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (27) : 4385 - 4393
  • [25] Imetelstat Is Effective Treatment for Patients with Intermediate-2 or High-Risk Myelofibrosis Who Have Relapsed on or Are Refractory to Janus Kinase Inhibitor Therapy: Results of a Phase 2 Randomized Study of Two Dose Levels
    Mascarenhas, John
    Komrokji, Rami S.
    Cavo, Michele
    Martino, Bruno
    Niederwieser, Dietger
    Reiter, Andreas
    Scott, Bart L.
    Baer, Maria R.
    Hoffman, Ronald
    Odenike, Olatoyosi
    Bussolari, Jacqueline
    Zhu, Eugene
    Huang, Fei
    Rose, Esther
    Sherman, Laurie
    Dougherty, Souria
    Feller, Faye M.
    Kiladjian, Jean-Jacques
    [J]. BLOOD, 2018, 132
  • [26] Comparison of intensive chemotherapy (CHT), allogeneic (ALLO) or autologous (AUTO) stem cell transplantation (SCT) as post-remission therapy in adults with high-risk ALL (HR-ALL). Results of randomized study PETHEMA ALL93
    Ribera, JM
    Ortega, JJ
    Oriol, A
    Fontanilias, M
    Parody, R
    Hernandez-Rivas, JM
    Rivas, C
    Del Potro, E
    Moreno, MJ
    Besalduch, J
    Fernandez-Calvo, J
    Bethencourt, C
    Tormo, M
    Arias, J
    Bueno, J
    Ortega, F
    Deben, G
    Moraleda, JM
    Vivancos, P
    Guinea, J
    Bello, JL
    Queizan, JA
    Feliu, E
    San Miguel, JF
    Sanz, MA
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S5 - S5
  • [27] High risk breast cancer (BC) patients (PTS) do not seem to have an increased relapse during the first 2 years in comparison to the whole population except those pts with N+>10.: Initial results of the NORA study
    Cazzaniga, ME
    Mustacchi, G
    Pronzato, P
    De Matteis, A
    Di Costanzo, F
    Porcu, L
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 274 - 275
  • [28] A prospective, randomized comparison of two doses of combination alkyating agents (AA) as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes (LN): Preliminary results of CALGB 9082/SWOG 9114/NCIC MA-13.
    Peters, W
    Rosner, G
    Vredenburgh, J
    Shpall, E
    Crump, M
    Richardson, P
    Marks, L
    Cirrincione, C
    Wood, W
    Henderson, I
    Hurd, D
    Norton, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) : 21B - 21B
  • [29] Randomized phase II trial comparing two strategies in high-risk rectal cancer (RC): Chemoradiation (CRT) followed by total mesorectal excision (TME) and adjuvant chemotherapy (CT) or induction CT followed by CRT and TME-Preliminary results of the multicenter GCR-3 study
    Fernandez-Martos, C.
    Pericay, C.
    Salud, A.
    Alonso, V.
    Massuti, B.
    Safont, M.
    Vera, R.
    Escudero, P.
    Maurel, J.
    Aparicio, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 Study
    Oberlin, Odile
    Rey, Annie
    Sanchez de Toledo, Jose
    Martelli, Helene
    Jenney, Meriel E. M.
    Scopinaro, Marcelo
    Bergeron, Christophe
    Merks, Johannes H. M.
    Bouvet, Nathalie
    Ellershaw, Caroline
    Kelsey, Anna
    Spooner, David
    Stevens, Michael C. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (20) : 2457 - 2465